ArticleLeukemia2024
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses.
Jeppe F Severens et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it